BHI Daily Update — Pullback Continues Amid KOSDAQ Selloff, Foreign Brokers Accumulate
BHI Daily Update — Pullback Continues Amid KOSDAQ Selloff, Foreign Brokers Accumulate
BHI fell 3.3% to ₩92,500, now 19% below its March 10 all-time high of ₩114,200. KOSDAQ dropped harder at -4.9%, suggesting BHI showed relative strength. Morgan Stanley and JP Morgan were net buyers. Institutional accumulation continues — +2.69M net shares over the past 100 days — but the last week shows selling pressure from both institutions and foreigners as the broader market weakens.
Price Action & Technicals
- Close: ₩92,500 (-3.34%), Range: ₩91,200 – ₩98,100
- Volume: 345,577 (below 20-day avg ~419K) — declining volume on the pullback, not capitulation
- 50-day MA: ₩83,776 — still well above; this is the next meaningful support
- 200-day MA: ₩56,137 — long-term uptrend firmly intact
- 52-week range: ₩15,270 – ₩114,200 (current price at 63rd percentile)
Key levels:
- Resistance: ₩98,100 (today's high), ₩105,000 (mid-March consolidation), ₩114,200 (ATH)
- Support: ₩91,200 (today's low), ₩83,776 (50d MA), ₩74,500 (March 4 crash low)
The stock is in a downtrend since March 10, making lower highs and lower lows. This is the second leg down — first was ₩114,200 → ₩99,200 (Mar 24), brief bounce to ₩104,800, now resuming lower. The March 4 V-shaped recovery bottom at ₩74,500 remains the critical line — as long as it holds, the higher-timeframe uptrend is intact.
BHI vs KOSDAQ
| Metric | BHI | KOSDAQ |
|---|---|---|
| 6-month return | +95.9% | +25.0% |
| From recent peak | -19.0% (Mar 10 ATH) | -11.8% (Feb 27 high) |
| Today | -3.3% | -4.9% |
| From Mar 4 low | +28.5% | +7.8% |
BHI is pulling back harder than KOSDAQ in percentage terms, consistent with its higher beta. Today it held up better than the index — not a stock-specific selloff. End-of-quarter rebalancing may be contributing to the broader market weakness.
Valuation
| Metric | Value |
|---|---|
| Market Cap | ₩2.86T |
| Trailing P/E | ~146x |
| EV/EBITDA (normalized) | ~88x |
| P/FCF | ~81x |
| EV/Revenue | ~7.3x |
These are extreme multiples by any conventional standard. BHI is priced not on current earnings (₩19.6B net income) but on the expectation of a multi-year nuclear component order cycle. The stock has been re-rated from deep-value (it was trading below tangible book in 2021) to a momentum/thematic name.
Fundamentals (FY2024)
| Item | FY2024 | FY2023 | YoY |
|---|---|---|---|
| Revenue | ₩404.7B | ₩367.4B | +10.2% |
| Gross Margin | 14.6% | 11.8% | +2.8pp |
| Operating Margin | 5.4% | 4.1% | +1.3pp |
| Net Income | ₩19.6B | ₩7.5B | +161% |
| FCF | ₩35.5B | ₩39.2B | -9.4% |
- Revenue growth steady at ~10%, margins expanding. The company went from ₩-34.6B net loss in 2021 to ₩19.6B profit in 2024.
- Net debt fell to ₩107.8B (from ₩142.3B), debt/equity improved to 1.09x (from 2.13x in 2023).
- Working capital remains deeply negative (-₩132.6B) — typical for EPC/heavy industrial companies with large advance payments and long project cycles.
- Accounts receivable jumped to ₩154.2B (from ₩103.2B), and accounts payable to ₩173.6B (from ₩106.0B) — indicates growing project volume but also working capital risk if collections slow.
Investor Flow (100-day aggregate)
| Investor Type | Net Shares | Direction |
|---|---|---|
| Institutional | +2,687,193 | Accumulating |
| Foreign | +3,380,424 | Accumulating |
| Retail | -6,067,617 | Distributing |
Foreign ownership: 12.34% (Oct 31) → 23.07% peak (Jan 7) → 20.14% (Mar 30). Foreign ownership nearly doubled in 3 months, then partially unwound.
Recent 5-day trend (Mar 24-30):
- Institutional: Net -122,520 (selling)
- Foreign: Net -29,444 (roughly flat)
- Retail: Net +151,964 (buying the dip)
The flow dynamic has shifted. The last week shows institutional profit-taking and foreigners turning neutral. Retail is now the marginal buyer — historically a bearish signal for Korean mid-caps.
Today's Broker Activity
| Side | Top Brokers |
|---|---|
| Buyers | Morgan Stanley (50,240), 신한투자 (49,832), 키움 (34,302), NH투자 (31,455), JP Morgan (24,995) |
| Sellers | 신한투자 (57,022), 미래에셋 (35,853), 키움 (32,509), 한국투자 (24,550), NH투자 (23,603) |
| Foreign Net | +36,594 shares |
Morgan Stanley and JP Morgan buying is notable — foreign institutional interest persists despite the pullback. 신한투자 on both sides at similar volume suggests market-making/program trading. Domestic brokers (미래에셋, 한국투자) are net sellers.
Buy Strategy
Short-term tactical: The pullback is approaching levels where the risk/reward improves, but it hasn't reached the 50-day MA (₩83,776) yet. The current pattern of lower highs since March 10, combined with institutional selling over the last week, suggests the correction may have further to go. Wait for either:
- A test and hold of the 50-day MA (~₩83,800) with a volume spike — this would be a higher-probability entry
- A reversal day with institutional net buying returning above +100K shares
Position sizing consideration: At 146x P/E, any position is a bet on the nuclear cycle thesis, not on current fundamentals. Size accordingly — this is a momentum trade, not a value trade.
Sell Strategy
For existing holders:
- If accumulated below ₩60,000: Consider trimming 20-30% on any bounce back to ₩100,000-105,000. The stock has nearly doubled and the near-term flow picture is deteriorating.
- Break below ₩83,800 (50d MA) with heavy volume would be a stop-loss trigger for momentum-based positions.
- Hard floor: ₩74,500 (March 4 crash low). A break below this level would indicate the uptrend has reversed.
Thesis invalidation: If nuclear order flow news turns negative (contract cancellations, regulatory delays beyond 2027), exit regardless of price level.